Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction

Clinical trial NCT06059066 · COMPLETED

Trial details

NCT number: NCT06059066
Sponsor: The Methodist Hospital Research Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Neurogenic Bladder Lower Urinary Tract Symptoms Overactive Bladder Neuro: Neurogenic Bladder Neurogenic Detrusor Overactivity

Start date: 2023-10-04
Primary completion: 2024-04-30
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.